Navigation Links
OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
Date:2/12/2013

www.OncoGenex.com.

OncoGenex' Forward Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning our anticipated product development activities, such as expected clinical trial completion and design and statements regarding the potential benefits and potential development of our product candidates. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements are subject to risks and uncertainties, including, among others, the risk that our product candidates will not demonstrate the hypothesized or expected benefits, the risk of delays in our expected clinical trials, the risk that new developments in the rapidly evolving cancer therapy landscape require changes in our clinical trial plans or limit the potential benefits of our product, the risk that our cash resources are insufficient to fund our planned activities for the time period expected and the other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
2. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
3. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
4. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
5. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
6. Misonix Announces New Distribution Agreement For Panama
7. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
10. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
11. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015   ICD-10 Charts ... months of development, it has officially launched its ... Charts Training Academy and the new 4 Step ... well as all other ICD-10 Charts resources and ... in America, completely free-of-charge.  With the release of ...
(Date:7/7/2015)... 2015 Research and ... the "Elemental Analysis Market by Type (Organic, ... Application (Life Sciences, Food and Beverage Testing, Environment ... report to their offering. The ... types, technologies, and applications. By type, the market ...
(Date:7/7/2015)... and FREMONT, Calif. , July 7, ... South Korea and Velos, Inc. have entered into ... eResearch for cancer research nationally throughout South Korea ... The recent agreement signing was accompanied by a two day ... , South Korea.  National Cancer Center President ...
Breaking Medicine Technology:ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3
... Oct. 6 According to Millennium Research Group ... intelligence, growth in the $2 billion US cardiac ... the expanded approval of Boston Scientific,s chronic resynchronization ... I and II patients. The New ...
... Oct. 6 e-MDs, an industry leader in ... (EHRs) and practice management (PM) solutions,  congratulates  the ... Family Medicine of Fort Collins, CO, for their ... of Excellence recipients.  The Healthcare Information and Management ...
Cached Medicine Technology:Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 3e-MDs Clients Win HIMSS Davies Awards of Excellence 2e-MDs Clients Win HIMSS Davies Awards of Excellence 3e-MDs Clients Win HIMSS Davies Awards of Excellence 4
(Date:7/7/2015)... ... July 07, 2015 , ... WiseWear®, a wearable ... their first line of luxury smart jewelry called the Socialite™ collection. The product ... this fall. , “The Socialite collection was crafted to inspire women to ...
(Date:7/7/2015)... ... July 07, 2015 , ... More ... Sun Dial and Howdy’s, raised more than $524,286 during the Muscular Dystrophy ... nearly $100,000, to help support children fighting muscular dystrophy and related life-threatening ...
(Date:7/7/2015)... ... July 07, 2015 , ... This week Northeast Nebraska ... new website. The website’s goal is to provide patients with detailed information about ... including requesting appointments online. , Part of the center’s rebranding efforts, the website ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Greatist ... newsletter and website that helps active people find the most fun activities to do ... lifestyle coverage for millennials. It also increases Greatist’s opportunity for events, e-commerce, and brand ...
(Date:7/7/2015)... ... , ... SC&H Group, a leading audit, tax, and consulting firm, recently hosted ... through company-wide volunteering efforts. , On an annual basis, in coordination with Business ... need throughout Baltimore and Washington D.C. , This year, SC&H Group’s team ...
Breaking Medicine News(10 mins):Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:SC&H Group Celebrates 9th Annual Day of Service 2
... ... Distinguished Professor of Critical Care Medicine at Children’s National Medical Center , ... Washington, DC (Vocus) March 24, ... L. Wessel, MD , as the first IKARIA® Distinguished Professor of Critical Care Medicine. ...
... cases are few after time, but death risk is ... (HealthDay News) -- Breast cancer recurrence in the same ... predictor of subsequent cancer spread and death in patients ... study has found. , Researchers analyzed data from 7,749 ...
... ... ... April of 2009, Director/Producer James Takata, Writers/Producers Zach Lewis and Jim Mahoney, and Producer ... a short film about Stephen, a talented young composer and pianist who discovers he ...
... This release is available in Spanish . ... that some breast cancer patients taking tamoxifen may not ... they have also been taking selective serotonin reuptake inhibitors ... important enzyme. Now researchers have developed a strategy for ...
... Despite the aches and pains that occur in old age, ... experiences from their past. A new study, reported in ... http://www.elsevier.com/locate/cortex ), reveals that older adults, ability to remember the ... in which the brain processes emotional content. In the ...
... ... Below is recent testimonial on how well the product works. This Herbal Tea can be ... ... Snoring. Below is recent testimonial on how well the product works. This Herbal Tea can ...
Cached Medicine News:Health News:$2.5 Million Gift Aims to Help Children Survive and Thrive 2Health News:$2.5 Million Gift Aims to Help Children Survive and Thrive 3Health News:Breast Cancer's Return in Original Tumor Site a Bad Sign 2Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 2Health News:Prize4Life Inspires Award-winning ALS Film: Trapped 3Health News:Doctors must collaborate so that patients get full benefit of tamoxifen treatment 2Health News:Doctors must collaborate so that patients get full benefit of tamoxifen treatment 3Health News:Older adults remember the good times 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 2Health News:Snoring Reduced With Relaxation Tea… Could It Be? 3
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: